Jade Biosciences, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Sale | 219 | $17.87 | $3,914 | 1,609 | Jul 5, 2023 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 10,000 | $18.00 | $180,000 | — | Jul 3, 2023 |
| Dake Benjamin T | SEE REMARKS | Option Exercise | 7,871 | $2.14 | $16,844 | 11,574 | Jun 6, 2023 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Option Exercise | 650 | $1.74 | $1,131 | 2,259 | Jun 5, 2023 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | Sale | 65 | $19.50 | $1,268 | 3,251 | May 19, 2023 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | Option Exercise | 1,090 | $1.74 | $1,897 | 4,341 | May 17, 2023 |
| Dake Benjamin T | SEE REMARKS | Sale | 1,599 | $22.74 | $36,361 | 1,291 | May 8, 2023 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Option Exercise | 1,600 | $2.14 | $3,424 | 3,859 | May 5, 2023 |
| Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | Sale | 759 | $20.79 | $15,780 | — | May 3, 2023 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Option Exercise | 15,000 | $2.14 | $32,100 | 15,693 | May 2, 2023 |
| Gillies Hunter | CHIEF MEDICAL OFFICER | Option Exercise | 4,000 | $1.74 | $6,960 | 5,960 | Apr 21, 2023 |
| Dake Benjamin T | SEE REMARKS | Sale | 10,283 | $18.17 | $186,842 | — | Apr 6, 2023 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Option Exercise | 1,600 | $2.14 | $3,424 | 3,859 | Apr 5, 2023 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 9,172 | $19.16 | $175,736 | 5,828 | Apr 3, 2023 |
| Dake Benjamin T | SEE REMARKS | Sale | 215 | $24.50 | $5,268 | — | Mar 6, 2023 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Sale | 2,205 | $23.73 | $52,325 | 1,654 | Mar 6, 2023 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 1,050 | $25.67 | $26,954 | — | Mar 1, 2023 |
| Dake Benjamin T | SEE REMARKS | Option Exercise | 7,872 | $2.14 | $16,846 | 10,284 | Feb 6, 2023 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Sale | 2,250 | $24.27 | $54,608 | 1,609 | Feb 6, 2023 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Option Exercise | 15,000 | $2.14 | $32,100 | 15,000 | Feb 1, 2023 |
| Dake Benjamin T | SEE REMARKS | Sale | 2,792 | $26.95 | $75,244 | — | Jan 6, 2023 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Sale | 2,250 | $26.40 | $59,400 | 1,609 | Jan 5, 2023 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 15 | $29.82 | $447 | — | Jan 3, 2023 |
| Eldridge George A | SEE REMARKS | Sale | 583 | $25.23 | $14,709 | 1,960 | Dec 12, 2022 |
| Dake Benjamin T | SEE REMARKS | Sale | 1,132 | $28.83 | $32,636 | 907 | Dec 12, 2022 |
| Dake Benjamin T | SEE REMARKS | Sale | 2,695 | $21.63 | $58,293 | 6,377 | Dec 9, 2022 |
| Eldridge George A | SEE REMARKS | Sale | 11,031 | $24.20 | $266,950 | 1,960 | Dec 8, 2022 |
| Dake Benjamin T | SEE REMARKS | Sale | 615 | $18.29 | $11,248 | — | Dec 6, 2022 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Option Exercise | 1,600 | $2.14 | $3,424 | 3,859 | Dec 5, 2022 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Option Exercise | 15,000 | $2.14 | $32,100 | 15,000 | Dec 1, 2022 |
| Eldridge George A | SEE REMARKS | Sale | 85 | $19.06 | $1,620 | 1,960 | Nov 30, 2022 |
| Eldridge George A | SEE REMARKS | Option Exercise | 1,261 | $2.14 | $2,699 | 3,221 | Nov 23, 2022 |
| Eldridge George A | SEE REMARKS | Sale | 81 | $20.13 | $1,631 | 1,960 | Nov 22, 2022 |
| Dake Benjamin T | SEE REMARKS | Option Exercise | 14,000 | $2.14 | $29,960 | 14,000 | Nov 11, 2022 |
| Dake Benjamin T | SEE REMARKS | Option Exercise | 2,413 | $1.74 | $4,199 | 2,413 | Nov 7, 2022 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Sale | 215 | $20.29 | $4,362 | 1,609 | Nov 7, 2022 |
| Verwijs Marinus | SENIOR VICE PRESIDENT, CMC | Sale | 1,130 | $18.89 | $21,346 | — | Nov 2, 2022 |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | Sale | 1,038 | $19.50 | $20,241 | — | Nov 1, 2022 |
| Dake Benjamin T | SEE REMARKS | Option Exercise | 5,705 | $2.14 | $12,209 | 5,705 | Oct 18, 2022 |
| Dake Benjamin T | SEE REMARKS | Sale | 4,185 | $20.16 | $84,370 | — | Oct 14, 2022 |
| Dake Benjamin T | SEE REMARKS | Option Exercise | 4,954 | $2.14 | $10,602 | 4,954 | Oct 10, 2022 |
| Dake Benjamin T | SEE REMARKS | Option Exercise | 10,629 | $2.14 | $22,746 | 13,040 | Oct 6, 2022 |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | Option Exercise | 650 | $1.74 | $1,131 | 2,259 | Oct 5, 2022 |
| Dake Benjamin T | SEE REMARKS | Sale | 272 | $18.77 | $5,105 | — | Sep 12, 2022 |
| Dake Benjamin T | See Remarks | Sale | 176 | $18.54 | $3,263 | — | Sep 9, 2022 |
| Dake Benjamin T | See Remarks | Sale | 4,138 | $18.98 | $78,539 | 606 | Sep 7, 2022 |
| NIVEN RALPH | Chief Scientific Officer | Option Exercise | 1,600 | $2.14 | $3,424 | 3,859 | Sep 6, 2022 |
| NIVEN RALPH | Chief Scientific Officer | Option Exercise | 650 | $1.74 | $1,131 | 2,259 | Aug 18, 2022 |
| Dake Benjamin T | See Remarks | Sale | 3,451 | $24.10 | $83,169 | — | Aug 16, 2022 |
| Dake Benjamin T | See Remarks | Sale | 11,940 | $24.06 | $287,276 | 780 | Aug 10, 2022 |